20 August 2026
Merck and Moderna's AI-designed cancer therapy passes final trial
First reported
The Neuron ran this on .
- Merck and Moderna tested an mRNA cancer treatment where AI algorithms analyze each patient's tumor mutations to design a personalized immune response.
- The therapy completed Phase 3 trials, the final stage before regulatory review, with positive results reported.
